(Q33853093)

29 July 2017

Whole exome sequence analysis of serous borderline tumors of the ovary (English)

1 reference

29 July 2017

Jeff Boyd

1

1 reference

29 July 2017

Biao Luo

2

1 reference

29 July 2017

Suraj Peri

3

1 reference

29 July 2017

Beth Wirchansky

4

1 reference

29 July 2017

Lucinda Hughes

5

1 reference

29 July 2017

Caitlin Forsythe

6

1 reference

29 July 2017

Hong Wu

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

14 June 2013

1 reference

29 July 2017

1 reference

29 July 2017

130

1 reference

29 July 2017

3

1 reference

29 July 2017

560-564

1 reference

describes a project that uses

29 July 2017

SQL

1 reference

26 June 2022

https://europepmc.org/article/PMC/PMC4083840

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Low-grade serous carcinomas of the ovary contain very few point mutations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Integrated genomic analyses of ovarian carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Advances in understanding cancer genomes through second-generation sequencing

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

The Sequence Alignment/Map format and SAMtools

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Fast and accurate short read alignment with Burrows-Wheeler transform

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083840

Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images

29 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

Serous borderline tumours of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

Germ line and somatic mutations of BRAF V599E in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.007

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23774303

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2013.06.007

1 reference

29 July 2017

1 reference

29 July 2017

1 reference